Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for November 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Chiron to make up shortfall in UK flu vaccine
Company to produce an extra 200,000 doses..(more)

 Which company has the industry's best R&D pipeline?
Take part in Pharmafocus' industry poll ..(more)

 AstraZeneca fights generic Nexium bid
AstraZeneca files US lawsuit against Ranbaxy..(more)

 PR as important as salesforces, say marketers
HCA survey ranks value of different media to marketers..(more)

 Amgen sues Roche over new anaemia treatment
Biotech challenges Roche over product patents ..(more)

 FDA clears Tamiflu in children after safety scare
EMEA conducts own investigation into Tamiflu use ..(more)

 Asthma drug warning hits GlaxoSmithKline
FDA safety warnings could hit Advair sales..(more)

 New antibody could be COPD breakthrough, say companies
New drug could be first to halt progress of disease..(more)

 Oxford and GSK to collaborate on cancer research in India
Collaboration to set up the country's first cancer trials network..(more)

 De Facto expands into med ed
De Facto Medica makes strong start..(more)

 Haringey spawns new NHS collaboration for Pfizer
Collaboration results in large-scale NHS Direct initiative ..(more)

 Patient demand brings Sativex to UK ahead of approval
Pain relief spray to be used on a named patient basis..(more)

 Which company is pharma's rising star?
Pharma employees vote for 'Most Admired' company..(more)

 Study results not IDEAL for Lipitor
Setback for Pfizer as main competitor fares better..(more)

 Stricter new UK industry code of practice launched
MHRA to monitor advertising and promotion more strictly..(more)

 Public's expectations of NHS too high, say doctors
Young doctors express views in BMA survey ..(more)

 Government should stay out of NHS medicines decisions, says ABPI
ABPI calls for additional government money for PCTs..(more)

 Complete prescribing power proposed for nurses and pharmacists
BMA warns of patient safety issues and training concerns..(more)

 New advertising checks could delay UK launches
MHRA determined to adopt harder line ..(more)

 MSD patient safety campaign tackles counterfeits
MSD looks to rebuild repuation after Vioxx..(more)

 Foundation Trust requirements relaxed
Government says three-star requirement too restrictive..(more)

 Health secretary backs Herceptin use
North Stoke PCT reverses decision on mother of four..(more)

 Tarceva receives approval for pancreatic cancer in the US
European approval expected in early 2006..(more)

 UK approval for severe asthma treatment Xolair
Decision from NICE expected next year..(more)

 Ebixa takes on Alzheimer's market leaders
Lundbeck's Alzheimer's treatment competes with leaders..(more)

 New Aptivus launched in Europe for resistant HIV
Boehringer Ingelheim's new treatment approved by EMEA..(more)

 Bextra suspension confirmed in EU
Bextra suspended because of safety concerns..(more)

 R&D Scoreboard poor gauge of pharma investment in the UK
Pharma companies shying away from investing in UK..(more)

 NHS clinical leaders oppose mergers
Government wants PCT reorganisation by October 2006..(more)

 Industry's European price 'free riding' claim refuted
BMJ paper challenges assertions..(more)

 US acquisitions a coup for Cambridge Antibody
CAT buys two promising oncology candidates..(more)

 NICE unveils fast track plans
ABPI worried that NICE could assess some drugs too early..(more)

 Agency to raise iron overload awareness for Novartis brand
Ruder Finn awarded UK contract for Exjade..(more)

 GSK loses out on UK Seroxat patent
House of Lords rules in favour of Synthon..(more)

 Herbal medicines must prove safety
Herbal medicines to face stricter EU regulation ..(more)

 Prescribing powers proposed for new NHS support workers
3,000 new healthcare support workers to provide clinical care ..(more)

 Tamiflu's frontline status a mixed blessing for Roche
Roche under pressure to waive patent on Tamiflu..(more)

 Galliard wins GSK and Pfizer accounts
Company to handle global PR account for GSK's Avodart ..(more)

 Don't blush...look before you flush'
Bowel Cancer UK launched with a new campaign ..(more)

 Radical change for NHS in Scotland
Kerr Report makes a number of recommendations..(more)

 NICE unveils fast track process
Selected life-saving drugs to be assessed under new system..(more)

 200,000 quitters to boost NRT sales
Partial smoking ban to incrase sales of NRT products..(more)

 Government retreat on handing over PCT services
Health secretary allows individual PCTs to decide..(more)

 Markets shocked by Pfizer sales slump
Pfizer head points to strong late stage pipeline..(more)

 National campaign promotes private healthcare
Health insurance companies promote healthcare benefits..(more)

 GSK inspires more confidence than shaky AstraZeneca
Shaky pipeline undermining stockmarket confidence in AZ..(more)

 Merck and Schering-Plough lifted by cholesterol joint venture
Cholesterol-lowering drugs gaining ground in US market..(more)

 UK patients invited to report side-effects
Nationwide pilot programme extends Yellow Card to patients..(more)

 Campaigners dismayed at unworkable partial smoking ban
Cancer Research UK unhappy with partial ban..(more)

 Tropical disease research centre to open in Liverpool
Centre to specialise in development of new tropical medicines ..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.